Skip to content
Screener

Aktis Oncology, Inc. AKTS Q4 2025 Annual earnings

Reported February 25, 2026

Revenue$4.6M
EPS-$60.17

Next report

Date not yet announced

FAQ

When did Aktis Oncology, Inc. report Q4 2025 earnings?
Aktis Oncology, Inc. (AKTS) reported Q4 2025 earnings on February 25, 2026.
What were Aktis Oncology, Inc.'s Q4 2025 revenue and EPS?
Aktis Oncology, Inc. reported revenue of $4.6M and eps of $-60.17 for Q4 2025.
How did Aktis Oncology, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 172.2% from $1.7M a year earlier and eps declined 4637.8% from $-1.27.
Where can I find Aktis Oncology, Inc.'s Q4 2025 SEC filings?
You can read the 10-K periodic report (0001193125-26-131748) directly on SEC EDGAR. The filing index links above go to sec.gov.